Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine

Raffaele Badolato, Silvano Sozzani, Fabio Malacarne, Susanna Bresciani, Maurilia Fiorini, Alessandro Borsatti, Alberto Albertini, Alberto Mantovani, Alberto G. Ugazio, Luigi D. Notarangelo

Research output: Contribution to journalArticle

Abstract

Wiskott-Aldrich syndrome (WAS) is an X-linked disorder characterized by trombocytopenia, eczema, and progressive decline of the immune function. In addition, lymphocytes and platelets from WAS patients have morphologic abnormalities. Since chemokines may induce morphologic changes and migration of leukocytes, we investigated the monocyte response to chemoattractants in cells from WAS patients with an identified mutation in the WAS protein gene. Here, we report that monocytes derived from four patients with molecularly defined typical WAS have a severely impaired migration in response to FMLP and to the chemokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α compared with normal donors. Conversely, neither MCP-1 binding to monocytes nor induction of the respiratory burst by MCP-1 and FMLP is significantly different between WAS patients and normal donors. Within a few minutes of stimulation, monocytes respond to chemokines with increased expression of adhesion molecules and with morphologic changes such as cell polarization. Although up-regulation of CD11b/CD18 expression following stimulation with FMLP or MCP-1 is preserved in WAS patients, cell polarization is dramatically decreased. Staining of F-actin by FITC- phalloidin in monocytes stimulated with chemoattractants shows F-actin to have a rounded shape in WAS patients, as opposed to the polymorphic distribution of F-actin in the polarized monocytes from healthy donors. These results suggest that WAS protein is involved in the monocyte response to the chemokines MCP-1 and macrophage inflammatory protein-1α.

Original languageEnglish
Pages (from-to)1026-1033
Number of pages8
JournalJournal of Immunology
Volume161
Issue number2
Publication statusPublished - Jul 15 1998

Fingerprint

methionyl-leucyl-phenylalanine
Wiskott-Aldrich Syndrome
Chemokine CCL2
Chemotaxis
Monocytes
Chemokines
Wiskott-Aldrich Syndrome Protein
Macrophage Inflammatory Proteins
Actins
Chemotactic Factors
Tissue Donors
Phalloidine
Respiratory Burst
Fluorescein-5-isothiocyanate
Eczema
Protein Binding
Leukocytes
Up-Regulation
Blood Platelets
Lymphocytes

ASJC Scopus subject areas

  • Immunology

Cite this

Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. / Badolato, Raffaele; Sozzani, Silvano; Malacarne, Fabio; Bresciani, Susanna; Fiorini, Maurilia; Borsatti, Alessandro; Albertini, Alberto; Mantovani, Alberto; Ugazio, Alberto G.; Notarangelo, Luigi D.

In: Journal of Immunology, Vol. 161, No. 2, 15.07.1998, p. 1026-1033.

Research output: Contribution to journalArticle

Badolato, Raffaele ; Sozzani, Silvano ; Malacarne, Fabio ; Bresciani, Susanna ; Fiorini, Maurilia ; Borsatti, Alessandro ; Albertini, Alberto ; Mantovani, Alberto ; Ugazio, Alberto G. ; Notarangelo, Luigi D. / Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. In: Journal of Immunology. 1998 ; Vol. 161, No. 2. pp. 1026-1033.
@article{eac81942cccf4d558dfc744cc9423a55,
title = "Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine",
abstract = "Wiskott-Aldrich syndrome (WAS) is an X-linked disorder characterized by trombocytopenia, eczema, and progressive decline of the immune function. In addition, lymphocytes and platelets from WAS patients have morphologic abnormalities. Since chemokines may induce morphologic changes and migration of leukocytes, we investigated the monocyte response to chemoattractants in cells from WAS patients with an identified mutation in the WAS protein gene. Here, we report that monocytes derived from four patients with molecularly defined typical WAS have a severely impaired migration in response to FMLP and to the chemokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α compared with normal donors. Conversely, neither MCP-1 binding to monocytes nor induction of the respiratory burst by MCP-1 and FMLP is significantly different between WAS patients and normal donors. Within a few minutes of stimulation, monocytes respond to chemokines with increased expression of adhesion molecules and with morphologic changes such as cell polarization. Although up-regulation of CD11b/CD18 expression following stimulation with FMLP or MCP-1 is preserved in WAS patients, cell polarization is dramatically decreased. Staining of F-actin by FITC- phalloidin in monocytes stimulated with chemoattractants shows F-actin to have a rounded shape in WAS patients, as opposed to the polymorphic distribution of F-actin in the polarized monocytes from healthy donors. These results suggest that WAS protein is involved in the monocyte response to the chemokines MCP-1 and macrophage inflammatory protein-1α.",
author = "Raffaele Badolato and Silvano Sozzani and Fabio Malacarne and Susanna Bresciani and Maurilia Fiorini and Alessandro Borsatti and Alberto Albertini and Alberto Mantovani and Ugazio, {Alberto G.} and Notarangelo, {Luigi D.}",
year = "1998",
month = "7",
day = "15",
language = "English",
volume = "161",
pages = "1026--1033",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine

AU - Badolato, Raffaele

AU - Sozzani, Silvano

AU - Malacarne, Fabio

AU - Bresciani, Susanna

AU - Fiorini, Maurilia

AU - Borsatti, Alessandro

AU - Albertini, Alberto

AU - Mantovani, Alberto

AU - Ugazio, Alberto G.

AU - Notarangelo, Luigi D.

PY - 1998/7/15

Y1 - 1998/7/15

N2 - Wiskott-Aldrich syndrome (WAS) is an X-linked disorder characterized by trombocytopenia, eczema, and progressive decline of the immune function. In addition, lymphocytes and platelets from WAS patients have morphologic abnormalities. Since chemokines may induce morphologic changes and migration of leukocytes, we investigated the monocyte response to chemoattractants in cells from WAS patients with an identified mutation in the WAS protein gene. Here, we report that monocytes derived from four patients with molecularly defined typical WAS have a severely impaired migration in response to FMLP and to the chemokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α compared with normal donors. Conversely, neither MCP-1 binding to monocytes nor induction of the respiratory burst by MCP-1 and FMLP is significantly different between WAS patients and normal donors. Within a few minutes of stimulation, monocytes respond to chemokines with increased expression of adhesion molecules and with morphologic changes such as cell polarization. Although up-regulation of CD11b/CD18 expression following stimulation with FMLP or MCP-1 is preserved in WAS patients, cell polarization is dramatically decreased. Staining of F-actin by FITC- phalloidin in monocytes stimulated with chemoattractants shows F-actin to have a rounded shape in WAS patients, as opposed to the polymorphic distribution of F-actin in the polarized monocytes from healthy donors. These results suggest that WAS protein is involved in the monocyte response to the chemokines MCP-1 and macrophage inflammatory protein-1α.

AB - Wiskott-Aldrich syndrome (WAS) is an X-linked disorder characterized by trombocytopenia, eczema, and progressive decline of the immune function. In addition, lymphocytes and platelets from WAS patients have morphologic abnormalities. Since chemokines may induce morphologic changes and migration of leukocytes, we investigated the monocyte response to chemoattractants in cells from WAS patients with an identified mutation in the WAS protein gene. Here, we report that monocytes derived from four patients with molecularly defined typical WAS have a severely impaired migration in response to FMLP and to the chemokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α compared with normal donors. Conversely, neither MCP-1 binding to monocytes nor induction of the respiratory burst by MCP-1 and FMLP is significantly different between WAS patients and normal donors. Within a few minutes of stimulation, monocytes respond to chemokines with increased expression of adhesion molecules and with morphologic changes such as cell polarization. Although up-regulation of CD11b/CD18 expression following stimulation with FMLP or MCP-1 is preserved in WAS patients, cell polarization is dramatically decreased. Staining of F-actin by FITC- phalloidin in monocytes stimulated with chemoattractants shows F-actin to have a rounded shape in WAS patients, as opposed to the polymorphic distribution of F-actin in the polarized monocytes from healthy donors. These results suggest that WAS protein is involved in the monocyte response to the chemokines MCP-1 and macrophage inflammatory protein-1α.

UR - http://www.scopus.com/inward/record.url?scp=0032528414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032528414&partnerID=8YFLogxK

M3 - Article

C2 - 9670984

AN - SCOPUS:0032528414

VL - 161

SP - 1026

EP - 1033

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -